flow trial semaglutide nejm effects of on kidneys Chronic Kidney Disease in Patients with Type 2 Diabetes The Effects of Semaglutide on

With more than a decade of experience in critical care, functional wellness, and preventive health, she combines deep medical expertise with a patient-first approach that focuses on long-term healing and vitality

Quantitative endpoints, such as MRI-PDFF and histology, can capture subtle yet clinically meaningful changes, whereas ALT/AST and ultrasonography may miss early metabolic improvements

Since control of diabetes and obesity are significant health outcome risk factors, it is conceivable that the shortages and high cost of GLP1 agonists will exacerbate existing health disparities. David Cutler, MD His perspective echoed what Ma told us, namely that [o]ne of the biggest bottlenecks with GLP-1RA access is cost and insurance. Even if a doctor prescribes [this type of drug], patients cannot obtain it if their insurance does not cover it, which could worsen disparities, especially for those with public insurance or in underserved populations, he also emphasized

placebo: 55% vs